Owners, management and financials
CVR: 31176891
Previous names: NORDIC BIOSCIENCE IMAGING A/S, SYNARC IMAGING TECHNOLOGY A/S
DKK -304,901
Gross profit
Net result: DKK -977,037
Screenpoint Medical B.V (100%)
CVR · view owners
Mads Nielsen
Board: Pieter Kroese (chair) and 2 members
CVR · view management
Active
Founded 1 January 2008
CVR · view overview
1 employee
CVR · 2026
Owner registered: Screenpoint Medical B.V
CVR · 02/01/2025
View the full event history
BIOMEDIQ A/S is a Danish company of the type Aktieselskab based in København K, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SYNARC IMAGING TECHNOLOGY A/S and NORDIC BIOSCIENCE IMAGING A/S. The management consists of Mads Nielsen. The board consists of Pieter Kroese (chair), Mads Nielsen and Martin Lillholm. The company is owned by Screenpoint Medical B.V. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -304,901 and a net result of DKK -977,037 compared with DKK -56,669 the year before. Equity in the 2025 report amounted to DKK -979,433.
Selskabets formål er at drive virksomhed indenfor bioteknologi og anden dermed i forbindelse stående virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | -977 t. | 310 t. | -979 t. | 1 | |
| 202401/01/2024 – 31/12/2024 | - | -57 t. | 40 t. | -2 t. | 1 | |
| 202301/01/2023 – 31/12/2023 | - | -58 t. | 119 t. | 54 t. | 1 | |
| 202201/01/2022 – 31/12/2022 | - | -320 t. | 226 t. | 113 t. | 1 | |
| 202101/01/2021 – 31/12/2021 | - | 247 t. | 1.1 mio. | 933 t. | 1 | |
| 202001/01/2020 – 31/12/2020 | - | 51 t. | 1.5 mio. | 1.2 mio. | 2 | |
| 201901/01/2019 – 31/12/2019 | - | 458 t. | 2.4 mio. | 1.1 mio. | - | |
| 201801/01/2018 – 31/12/2018 | 2.2 mio. | 633 t. | 3.2 mio. | 652 t. | 3 | |
| 201701/01/2017 – 31/12/2017 | 1.8 mio. | -349 t. | 3 mio. | 18 t. | 3 | |
| 201601/01/2016 – 31/12/2016 | 3 mio. | -915 t. | 3.9 mio. | 367 t. | 5 | |
| 201501/01/2015 – 31/12/2015 | 6.8 mio. | -203 t. | 2.5 mio. | 1.3 mio. | - | |
| 201401/01/2014 – 31/12/2014 | 7.5 mio. | 51 t. | 3.3 mio. | 1.5 mio. | - | |
| 201301/01/2013 – 31/12/2013 | 5.9 mio. | 24 t. | 3.5 mio. | 435 t. | - | |
| 201201/01/2012 – 31/12/2012 | 6.6 mio. | 51 t. | 3.6 mio. | 410 t. | - |
Compared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of BIOMEDIQ A/S is 31176891.
BIOMEDIQ A/S is owned by Screenpoint Medical B.V.
The management of BIOMEDIQ A/S consists of Mads Nielsen.
The board of BIOMEDIQ A/S consists of Pieter Kroese, Mads Nielsen and Martin Lillholm, with Pieter Kroese as chair.
In 2025, BIOMEDIQ A/S reported a gross profit of DKK -304,901.
BIOMEDIQ A/S had 1 employee in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
BIOMEDIQ A/S has published its annual report for 2025. Gross profit came to DKK -304,901, and the net result was DKK -977,037.
Contact info changed: new phone: 24600599 (June 2, 2026).
BIOMEDIQ A/S has published its annual report for 2024. Gross profit came to DKK -74,987, and the net result was DKK -56,669.
As of January 2, 2025, Pieter Kroese has joined the board of directors of BIOMEDIQ A/S.
As of January 2, 2025, Erik Bjørnager Dam has left the board of directors of BIOMEDIQ A/S.
As of January 2, 2025, is registered as an owner of BIOMEDIQ A/S with an ownership share of 100%.
As of June 24, 2024, DANSK REVISION SØBORG, STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of BIOMEDIQ A/S.
BIOMEDIQ A/S has published its annual report for 2023. Gross profit came to DKK -50,807, and the net result was DKK -58,488.
BIOMEDIQ A/S has published its annual report for 2022. Gross profit came to DKK 11,758, and the net result was DKK -319,974.
BIOMEDIQ A/S has published its annual report for 2021. Gross profit came to DKK 547,513, and the net result was DKK 246,546.
BIOMEDIQ A/S has published its annual report for 2020. Gross profit came to DKK 1,023,002, and the net result was DKK 51,275.
BIOMEDIQ A/S has published its annual report for 2019. Gross profit came to DKK 1,637,907, and the net result was DKK 458,265.
As of October 15, 2019, DANSK REVISION SØBORG, STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of BIOMEDIQ A/S.
As of October 15, 2019, AIDER Godkendt Revisionsaktieselskab has stepped down as auditor of BIOMEDIQ A/S.
BIOMEDIQ A/S has published its annual report for 2018. Revenue came to DKK 2,175,224, and the net result was DKK 633,152.
BIOMEDIQ A/S has published its annual report for 2017. Revenue came to DKK 1,759,691, and the net result was DKK -348,790.
BIOMEDIQ A/S has published its annual report for 2016. Revenue came to DKK 2,981,218, and the net result was DKK -915,374.
BIOMEDIQ A/S has published its annual report for 2015. Revenue came to DKK 6,753,937, and the net result was DKK -203,231.
As of May 18, 2016, AIDER Godkendt Revisionsaktieselskab has been appointed auditor of BIOMEDIQ A/S.
As of May 18, 2016, CARSTEN C. HOFF REGNSKAB ApS has stepped down as auditor of BIOMEDIQ A/S.
As of April 25, 2016, Claus Henrik Christiansen has left the board of directors of BIOMEDIQ A/S.
As of April 25, 2016, Thomas Nielsen has left the board of directors of BIOMEDIQ A/S.
BIOMEDIQ A/S has published its annual report for 2014. Revenue came to DKK 7,509,302, and the net result was DKK 51,013.
As of May 7, 2015, CARSTEN C. HOFF REGNSKAB ApS has been appointed auditor of BIOMEDIQ A/S.
As of May 7, 2015, BRØNSHØJ REVISION ApS GODKENDTE REVISORER has stepped down as auditor of BIOMEDIQ A/S.
As of March 16, 2015, Claus Henrik Christiansen has joined the board of directors of BIOMEDIQ A/S.
As of March 16, 2015, Thomas Nielsen has joined the board of directors of BIOMEDIQ A/S.
BIOMEDIQ A/S has published its annual report for 2013. Revenue came to DKK 5,934,540, and the net result was DKK 24,423.
As of May 1, 2014, BRØNSHØJ REVISION ApS GODKENDTE REVISORER has been appointed auditor of BIOMEDIQ A/S.
As of May 1, 2014, HANS BEIER ApS has stepped down as auditor of BIOMEDIQ A/S.
BIOMEDIQ A/S has published its annual report for 2012. Revenue came to DKK 6,637,825, and the net result was DKK 50,652.
As of October 12, 2011, HANS BEIER ApS has been appointed auditor of BIOMEDIQ A/S.
As of October 12, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of BIOMEDIQ A/S.
As of April 7, 2011, Erik Bjørnager Dam has joined the board of directors of BIOMEDIQ A/S.
As of April 7, 2011, Martin Lillholm has joined the board of directors of BIOMEDIQ A/S.
As of April 7, 2011, Mads Nielsen has joined the board of directors of BIOMEDIQ A/S.
As of April 7, 2011, Thomas Nielsen has left the board of directors of BIOMEDIQ A/S.
As of April 7, 2011, Aaron Christopher Timm has left the board of directors of BIOMEDIQ A/S.
As of April 7, 2011, Ralph J. Reyes has left the board of directors of BIOMEDIQ A/S.
As of April 7, 2011, Mads Nielsen is registered as director of BIOMEDIQ A/S.
As of April 7, 2011, Søren Hyllekvist has stepped down as director of BIOMEDIQ A/S.
On April 7, 2011, the company changed its name from SYNARC IMAGING TECHNOLOGY A/S to BIOMEDIQ A/S.
As of October 26, 2009, Søren Hyllekvist is registered as director of BIOMEDIQ A/S.
As of October 26, 2009, Thomas Nielsen has stepped down as director of BIOMEDIQ A/S.
On October 26, 2009, the company changed its name from NORDIC BIOSCIENCE IMAGING A/S to SYNARC IMAGING TECHNOLOGY A/S.
As of February 23, 2009, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of BIOMEDIQ A/S.
As of February 23, 2009, Ankjær-Jensen & Partnere I/S, Statsautoriserede Revisorer has stepped down as auditor of BIOMEDIQ A/S.
As of November 1, 2008, Aaron Christopher Timm has joined the board of directors of BIOMEDIQ A/S.
As of November 1, 2008, Ralph J. Reyes has joined the board of directors of BIOMEDIQ A/S.
As of November 1, 2008, Claus Henrik Christiansen has left the board of directors of BIOMEDIQ A/S.
As of November 1, 2008, Morten Asser Karsdal has left the board of directors of BIOMEDIQ A/S.
As of November 1, 2008, Thomas Nielsen is registered as director of BIOMEDIQ A/S.
As of November 1, 2008, Claus Henrik Christiansen has stepped down as director of BIOMEDIQ A/S.
As of January 1, 2008, Ankjær-Jensen & Partnere I/S, Statsautoriserede Revisorer has been appointed auditor of BIOMEDIQ A/S.
As of January 1, 2008, Claus Henrik Christiansen has joined the board of directors of BIOMEDIQ A/S.
As of January 1, 2008, Thomas Nielsen has joined the board of directors of BIOMEDIQ A/S.
As of January 1, 2008, Morten Asser Karsdal has joined the board of directors of BIOMEDIQ A/S.
As of January 1, 2008, Claus Henrik Christiansen is registered as director of BIOMEDIQ A/S.
BIOMEDIQ A/S was founded on January 1, 2008.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at drive forretning med digital markedsføring og strategi samt enhver i forbindelse hermed stående virksomhed.
Companies in the same industry and area
CVR 40633979
CVR 45841227
CVR 31888263
CVR 35249389
CVR 37663808
